Furthermore, uptake of Tf-cisplatin in cancer cells was not mediated by copper (cisplatin) transporting proteins, which may explain the lack of changes in expression levels of MDR1, ERCC1 and LRP in Tf-cisplatin treated cells compared to controls. Here, ERCC1 is linked to cancer.